← Open Payments lookup

JOEL AMBROSIO: Open Payments

NPI 1154628105 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,254 in 43 payments from 12 companies in 2025. Trend: 2023 $806 · 2024 $1,723 · 2025 $1,254

Food & beverage: $1,254
CompanyPaymentsAmount
Lilly USA, LLC11$448
Madrigal Pharmaceuticals6$196
ABBVIE INC.8$187
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$120
QOL Medical, LLC3$75
Takeda Pharmaceuticals U.S.A., Inc.3$71
Janssen Biotech, Inc.2$46
Gilead Sciences, Inc.1$34
Organon LLC1$26
Phathom Pharmaceuticals, Inc.1$18

Products named: OMVOH, REZDIFFRA, RINVOQ, XIFAXAN, Sucraid, TREMFYA, EOHILIA, ENTYVIO.

Industry payments across CA — which companies pay providers there.